Last reviewed · How we verify

NCT05432908

Effect of Orofacial Myofunctional Therapy on Mouth Air Leak in Patients With Sleep Apnea Treated With CPAP

Terminated NA Last updated 10 April 2024
What this trial tests

NA trial testing Orofacial exercises and oropharyngeal functions in OSA in 20 participants. Terminated before completion.

Timeline
28 July 2017
Primary endpoint
30 June 2021
1 July 2021

Quick facts

Lead sponsorUniversity of Sao Paulo General Hospital
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment20
Start date28 July 2017
Primary completion30 June 2021
Estimated completion1 July 2021
Sites1 location across Brazil

Drugs / interventions tested

Conditions studied

Sponsor

University of Sao Paulo General Hospital

Who can join

18 and older, any sex, with OSA or Apnea+Hypopnea. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To verify the effect of orofacial myofunctional therapy in patients with OSA during the use of CPAP with a nasal mask, on the frequency and leak flow. In addition, the impact on mouth opening frequency, sleep quality, perception of excessive daytime sleepiness, and CPAP adherence will be evaluated.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for OSA

Currently open trials in the same condition.

Other University of Sao Paulo General Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05432908.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing